Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T16:17:06.172Z.
Calculation as of: 2026-10-06T16:17:06.172Z.
Quote observation: 2026-10-06T16:14:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 767633254d5919bd59cda52a5696942c7bb29bc9076435c5b91744fa0c767718
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Werewolf Therapeutics, Inc.
Market Cap
$45.09M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.62M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.14M
Price/FCF Ratio
N/A
TTM Avg
19.80
3Y Avg
20.69
5Y Avg
119.64
Market Cap
$48.27M
Price/FCF Ratio
N/A
TTM Avg
99.30
3Y Avg
99.30
5Y Avg
93.30
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.09M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.62M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.35M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.97M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.05M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | N/A | 19.80 | 20.69 | 119.64 |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.27M | N/A | 99.30 | 99.30 | 93.30 |
| Precipio, Inc. (PRPO)vs › | $42.61M | 54.01 | 75.00 | 61.77 | 61.77 |
| Lite Strategy, Inc. (LITS)vs › | $48.65M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.67M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
